Kopp Investment Advisors’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.15M Sell
67,390
-65,534
-49% -$1.19M 2.11% 17
2019
Q2
$3.02M Sell
132,924
-28,184
-17% -$760K 3.45% 14
2019
Q1
$5.18M Sell
161,108
-479
-0.3% -$14.8K 4.19% 9
2018
Q4
$4.55M Sell
161,587
-24,974
-13% -$731K 4.44% 5
2018
Q3
$5.36M Sell
186,561
-4,821
-3% -$145K 4.51% 6
2018
Q2
$7.17M Sell
191,382
-5,394
-3% -$212K 6.72% 1
2018
Q1
$7.73M Sell
196,776
-5,167
-3% -$189K 7.86% 1
2017
Q4
$6.54M Sell
201,943
-22,429
-10% -$673K 6.55% 1
2017
Q3
$6.99M Sell
224,372
-77,591
-26% -$2.3M 6.4% 2
2017
Q2
$8.44M Sell
301,963
-51,288
-15% -$1.16M 7.56% 2
2017
Q1
$6.06M Sell
353,251
-4,544
-1% -$63.6K 5.92% 2
2016
Q4
$4.33M Buy
357,795
+119,097
+50% +$1.54M 4.57% 3
2016
Q3
$3.78M Sell
238,698
-406,380
-63% -$6.12M 3.74% 6
2016
Q2
$8.34M Buy
645,078
+156,435
+32% +$2.45M 4.44% 6
2016
Q1
$9.28M Sell
488,643
-69,696
-12% -$1.26M 5.06% 4
2015
Q4
$12.6M Buy
558,339
+119,530
+27% +$2.36M 6.18% 4
2015
Q3
$10.3M Buy
438,809
+21,021
+5% +$580K 5.52% 4
2015
Q2
$12M Buy
417,788
+335,351
+407% +$8.79M 5.33% 5
2015
Q1
$2.13M Buy
+82,437
New +$1.89M 0.94% 25

Other funds holding XENT

Kopp Investment Advisors's XENT Position: Q3 2019 in Review

Kopp Investment Advisors reduced its Intersect ENT, Inc (XENT) stake by 49% in Q3 2019, selling an estimated $1.19M and leaving 67,390 shares worth $1.15M. The position accounts for 2.11% of the portfolio, ranked #17.

Kopp Investment Advisors first reported a position in XENT in Q1 2015 and has held it in 19 quarters since. The position peaked at $12.6M in Q4 2015. 112 funds tracked by Wall St. Rank hold XENT as of Q3 2019.

  • Kopp Investment Advisors held 67,390 shares of Intersect ENT, Inc worth $1.15M as of Q3 2019.
  • Kopp Investment Advisors sold 65,534 Intersect ENT, Inc shares in Q3 2019, an estimated $1.19M.
  • Intersect ENT, Inc made up 2.11% of Kopp Investment Advisors's portfolio in Q3 2019, its #17 holding.
  • Kopp Investment Advisors first reported a position in Intersect ENT, Inc in Q1 2015 and has held it in 19 quarters since.
  • Kopp Investment Advisors's Intersect ENT, Inc position peaked at $12.6M in Q4 2015.
  • 112 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2019.

Based on Kopp Investment Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.